Intracranial abnormalities and headache: A population-based imaging study (HUNT MRI)

Cephalalgia

Volumn 36, Issue 2, 2016, Pages 113-121

  Honningsvåg, Lasse Marius ^a   Hagen, Knut ^a,b   Håberg, Asta ^a   Stovner, Lars Jacob ^a,b   Linde, Mattias ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

cerebral infarction; cysts; Health survey; malformations; migraine; pathology; tension type headache; unclassified headache; white matter

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRAIN CYST; BRAIN DISEASE; BRAIN TUMOR; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEADACHE; HUMAN; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; QUESTIONNAIRE; TENSION HEADACHE; WHITE MATTER; ABNORMALITIES; BRAIN; MIDDLE AGED; NORWAY; NUCLEAR MAGNETIC RESONANCE IMAGING;

AGED; BRAIN; FEMALE; HEADACHE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NORWAY;

EID: 84955320029     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102415583147     Document Type: Article

References (37)

1. Stovner LJ, Andree C,. Prevalence of headache in Europe: A review for the Eurolight project. J Headache Pain 2010; 11: 289-299.
2. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163-2196.
3. Headache Classification Subcommittee of the International Headache Society. The International Classification of headache disorders (second edition). Cephalalgia 2004; 24 (Suppl 1): 1-160.
4. International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808.
5. Peres M, Zukerman E, Porto PP, et al. Headaches and pineal cyst: A (more than) coincidental relationship? Headache 2004; 44: 929-930.
6. Peres M,. Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia 2005; 25: 403-411.
7. Seifert CL, Woeller A, Valet M, et al. Headaches and pineal cyst: A case-control study. Headache 2008; 48: 448-452.
8. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291: 427-434.
9. Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts. JAMA 2009; 301: 2563-2570.
10. Schürks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: Systematic review and meta-analysis. BMJ 2009; 339: b3914-b3914.
11. Spector JT, Kahn SR, Jones MR, et al. Migraine headache and ischemic stroke risk: An updated meta-analysis. Am J Med 2010; 123: 612-624.
12. Kurth T, Mohamed S, Maillard P, et al. Headache, migraine, and structural brain lesions and function: Population based Epidemiology of Vascular Ageing-MRI study. BMJ 2011; 342: c7357-c7357.
13. Frishberg BM,. The utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations. Neurology 1994; 44: 1191-1197.
14. Frishberg B, Rosenberg J, Matchar DB, et al. Evidence-based guidelines in the primary care setting: Neuroimaging in patients with nonacute headache, http://tools.aan.com/professionals/practice/pdfs/gl0088.pdf. (2000, accessed 15 February 2013).
15. McCrory DC, Matchar DB, Gray RN, et al. Evidence-based guidelines for migraine headache: Overview of program description and methodology, http://tools.aan.com/professionals/practice/pdfs/gl0086.pdf (2000, accessed 17 February 2013).
16. Sempere A, Porta-Etessam J, Medrano V, et al. Neuroimaging in the evaluation of patients with non-acute headache. Cephalalgia 2005; 25: 30-35.
17. Wang HZ, Simonson TM, Greco WR, et al. Brain MR imaging in the evaluation of chronic headache in patients without other neurologic symptoms. Acad Radiol 2001; 8: 405-408.
18. Tsushima Y, Endo K,. MR imaging in the evaluation of chronic or recurrent headache. Radiology 2005; 235: 575-579.
19. Holmen J, Midthjell K, Bjartveit K, et al. The Nord-Trøndelag Health Survey 1984-86. Purpose, background and methods. Participation, non-participation and frequency distributions, http://www.ntnu.no/c/document-library/get-file?uuid=4be1f10f-be02-484d-a033-6194748bd5f4&groupId=10304 (1989, accessed 2 February 2012).
20. Holmen J, Midthjell K, Krüger Ø et al. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): Objectives, contents, methods and participation. Nor Epidemiol 2003; 13: 19-32.
21. Holmen J, Midthjell K, Forsén L, et al. A health survey in Nord-Trøndelag 1984-86. Participation and comparison of attendants and non-attendants [article in Norwegian]. Tidsskr Nor Laegeforen 1990; 110: 1973-1977.
22. Krokstad S and Knudtsen MS. Public health development, The HUNT Study, Norway; HUNT 1 (1984-86)-HUNT 2 (1995-97)-HUNT 3 (2006-08) Folkehelse i endring: Helseundersøkelsen Nord-Trøndelag; HUNT 1 (1984-86)-HUNT 2 (1995-97)-HUNT 3 (2006-08) [article in Norwegian], http://www.ntnu.no/documents/10304/1130562/folkehelse-i-endring-huntrapport-2011.pdf (2011, accessed 10 February 2012).
23. Torvik FA, Rognmo K, Tambs K,. Alcohol use and mental distress as predictors of non-response in a general population health survey: The HUNT study. Soc Psychiatry Psychiatr Epidemiol 2012; 47: 805-816.
24. Honningsvåg L-M, Linde M, Håberg A, et al. Does health differ between participants and non-participants in the MRI-HUNT study, a population based neuroimaging study? The Nord-Trøndelag health studies 1984-2009. BMC Med Imaging 2012; 12: 23-23.
25. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol 1987; 149: 351-356.
26. Hagen K, Zwart JA, Aamodt AH, et al. The validity of questionnaire-based diagnoses: The third Nord-Trøndelag Health Study 2006-2008. J Headache Pain 2010; 11: 67-73.
27. Mayfield D, McLeod G, Hall P,. The CAGE questionnaire: Validation of a new alcoholism screening instrument. Am J Psychiatry 1974; 131: 1121-1123.
28. Fazekas F,. Magnetic resonance signal abnormalities in asymptomatic individuals: Their incidence and functional correlates. Eur Neurol 1989; 29: 164-168.
29. Linde M, Stovner LJ, Zwart JA, et al. Time trends in the prevalence of headache disorders. The Nord-Trondelag Health Studies (HUNT 2 and HUNT 3). Cephalalgia 2011; 31: 585-596.
30. Tronvik E, Stovner LJ, Hagen K, et al. High pulse pressure protects against headache: Prospective and cross-sectional data (HUNT study). Neurology 2008; 70: 1329-1336.
31. Aamodt AH, Stovner LJ, Hagen K, et al. Headache prevalence related to smoking and alcohol use. The Head-HUNT Study. Eur J Neurol 2006; 13: 1233-1238.
32. Morris Z, Whiteley WN, Longstreth WT, et al. Incidental findings on brain magnetic resonance imaging: Systematic review and meta-analysis. BMJ 2009; 339: b3016-b3016.
33. Al-Holou WN, Terman S, Kilburg C, et al. Prevalence and natural history of arachnoid cysts in adults. J Neurosurg 2013; 118: 222-231.
34. van Dijk EJ, Breteler MMB, Schmidt R, et al. The association between blood pressure, hypertension, and cerebral white matter lesions: Cardiovascular determinants of dementia study. Hypertension 2004; 44: 625-630.
35. Jordan JE, Ramirez GF, Bradley WG, et al. Economic and outcomes assessment of magnetic resonance imaging in the evaluation of headache. J Natl Med Assoc 2000; 92: 573-578.
36. Swartz RH, Kern RZ,. Migraine is associated with magnetic resonance imaging white matter abnormalities: A meta-analysis. Arch Neurol 2004; 61: 1366-1368.
37. Kruit MC, Launer LJ, Ferrari MD, et al. Brain stem and cerebellar hyperintense lesions in migraine. Stroke 2006; 37: 1109-1112.